Dr. Hall is an Associate Professor of Pharmacology and Experimental Therapeutics in the College of Pharmacy and Pharmaceutical Sciences at the University of Toledo. He is recognized internationally as an expert in the genetic basis of addiction and the role that early social experience plays in shaping adult behavior and behavioral pathology. After a B.A. from Harvard University (1987) and a Ph.D. from the University of Cambridge (1994), Dr. Hall completed a National Research Council Research Associateship at the National Institute on Alcoholism and Alcohol Abuse. His research during this time focused on animal models of schizophrenia and alcohol use disorder that led to his long-standing interests in genetic and experiential models of psychiatric disorders. Dr. Hall joined the Molecular Neurobiology Branch at the National Institute on Drug Abuse in 1999 where he led a behavioral genetics group in the Molecular Neurobiology Branch until 2014.  Dr. Hall’s laboratory at the University of Toledo investigates the genetic and environmental determinants of susceptibility to addiction and related psychiatric disorders, and drug toxicity associated with novel addictive drugs. His long-standing interest in the underlying mechanisms that lead to the development of psychopathology has contributed to advancement of models used to identify novel potential targets for the treatment of psychiatric disorders. Moreover, he has contributed intellectually to the conceptualization of approaches to modeling psychiatric disorders for drug development, the topic of a book he edited with Jared Young and Andre Der-Avakian, Negative Affective States and Cognitive Impairments in Nicotine Dependence (Elsevier, 2016). Dr. Hall has authored over a hundred scientific publications. He is a fellow of the International Behavioral Neuroscience Society and the current Past-President of that society.